期刊文献+

胺碘酮对起搏器术后快速心律失常的疗效与安全性

On the proofs to the effectiveness and safety in taking amiodarone orally when any immediate cardiac arrhythmia occurs.
下载PDF
导出
摘要 目的研究口服胺碘酮对起搏器术后各种快速心律失常的疗效和安全性,为安置人工心脏起搏器后伴发快速心律失常患者口服胺碘酮是否有效和安全提供证据。方法对36例置入永久心脏起搏器并口服胺碘酮治疗快速心律失常的患者进行疗效观察,并跟踪监测心室起搏阈值。另外40例为对照组、监测心室起搏阈值。结果胺碘酮有效率83.3%。术后两组均有心室起搏阈值升高。两组相比较,胺碘酮组较对照组升高更明显。结论胺碘酮对起搏器术后心室起搏阈值有一定影响,但仍在安全范围。 Objective This research aims at finding out the proofs to the effective and safety in taking amiodarone orally when any kind of immediate cardiac arrhythmla occurs It is known that patients may suffer from any kind of immediate cardiac arrhythmia after artifical pacemakers are put in them.In this case,surgeons usually ask patients to take amiodarone orally. Method By looking closely into thirty-six cases of patients,who were put amiodarone orally to centrol the immediate cardiac arrhythmia,the researcher tries to observe the effectiveness in the treatment and check the threshold value of pacing impulse in ventricle. In addition ,the researcher has also observed forty cormpartive cases of patients to check the threshold value. Results The effective rate of the treatment is 83.3%. The two groups of the patients have almost experienced the rise in the threshold value of pacing impulse in ventricle. By comparison ,the riseing the threshold value of patients who took amiodarone orally is more obvious. Conclusion It is con- cluded that after the operation amiodarone has certain effect on the threshold value but within the safe range.
作者 方长太
出处 《临床心电学杂志》 2005年第3期199-201,共3页 Journal of Clinical Electrocardiology
关键词 心脏起搏 永久 胺碘酮 心律失常 快速 Artificial Pacemaker Permanence Amiodarone Cardiac Arrhythmia, Immediate
  • 相关文献

参考文献5

二级参考文献12

  • 1Echt DS, Liebson PR, Peters RW, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the cardiac arrhythmia suppression trial[J]. N Engl J Med, 1991, 324:781 - 788.
  • 2The Cardiac Arrhythmia Suppression Trial Ⅱ Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction [J]. N Engl J Med, 1992, 327:227-233.
  • 3Siebls J, Cappato R, Ruppel R, et al. Preliminary results of cardiac arrest study hambury(CASH) [J]. Am J Cardiol, 1993, 72: 109F -113F.
  • 4Hine LK, Laird N, Hewittp P, et al. Meta- analytic evidence against prophylactic use of lidocaine in acute myocardial infarction [ J ]. Arch Intern Med, 1989, 149:2694 - 2698.
  • 5Doval HC, Nul DR, Grancelli HO, et al. Randomized trial of low - dose amiodarone in severe congestive heart failure[J]. Lancet, 1994, 344:493-499.
  • 6Kreiss Y, Sidi Y, Gur H. Efficacy and safety of intravenous amiodarone in recent onset atrial fibrillation: experience in patients admitted to a general internal medicine department[ J ]. Postgrad Med J, 1999, 75: 278- 281.
  • 7Roy D, Talajic M, Dorian P. Amiodarone to prevent recurrence of a trial fibrillation. N Engl J Med, 2002,342:9-12.
  • 8Bianconi L, Koccadamo R, Toscano S, et al. Effects of oral propafenone therapy on chronic myocardial pacing threhold. PACE, 1992,15: 148- 154.
  • 9Massimo Santini,Claudio Pandozi,Renato Ricci. Combining Antiarrhythmic Drugs and Implantable Devices Therapy: Benefits and Outcome[J] 2000,Journal of Interventional Cardiac Electrophysiology(1):65~68
  • 10抗心律失常药物治疗专题组.抗心律失常药物治疗建议[J].中华心血管病杂志,2001,29(6):323-336. 被引量:788

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部